Search filters

List of works by Jacopo Giuliani

A path for diagnosis and therapy of colon cancer: a continuous quality improvement

scientific article

A severe delayed infusion reaction induced by trastuzumab: a life-threatening condition ⬇️

scientific article published on 07 July 2012

Acute Liver Failure Caused by Metastatic Breast Cancer: Can We Expect Some Results from Chemotherapy?

scientific article published on 19 June 2015

Ampulla of Vater carcinoma in real-world clinical practice: a case series.

scientific article published on 25 June 2015

Anti-angiogenic agents in second-line treatment for metastatic colorectal cancer: the optimization of pharmacological costs

scientific article published on 26 May 2018

COVID-19 and Cancer: A Clear Change Not Only in Daily Clinical Practice But Also in Clinical Research Management

scientific article published on 20 November 2020

Cancer prevales on COVID-19: To maintain high quality standard concerning diagnosis and oncological care even during a pandemic

scientific article published on 17 June 2020

Cancer relating symptoms in homecare cancer patients: which impact in daily clinical practice?

scientific article published on 22 June 2013

Carboplatin-containing regimens as front-line treatment for advanced non-small-cell lung cancer in two groups of elderly.

scientific article

Case Report of a Well-Differentiated Papillary Mesothelioma of the Tunica Vaginalis in an Undescended Testis With Review of Literature.

scientific article published on 12 February 2016

Centrosome Linker-induced Tetraploid Segregation Errors Link Rhabdoid Phenotypes and Lethal Colorectal Cancers

scientific article published on 21 May 2018

Cisplatin versus cetuximab given concomitantly with radiotherapy in non-resectable head and neck squamous cell carcinoma: an open question

scientific article published on 25 February 2015

Colonic Ewing Sarcoma/PNET associated with liver metastases: A systematic review and case report

scientific article published on 29 November 2018

Cost-Effectiveness of Second-Line Treatments for Metastatic Renal-Cell Carcinoma

scientific article published on 22 November 2018

Cost-effectiveness of first-line hormone-therapies in chemonaïve castration-resistant prostate cancer Integrating the European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS) with the costs of drugs.

scientific article published in June 2017

Economic sustainability of nivolumab at flat dose for second-line treatment of metastatic non-small cell lung cancer in real life

scientific article published on 10 June 2019

Elderly patients with advanced pancreatic cancer: the generalizability of the results of clinical trials to daily clinical practice

scientific article published on 01 March 2017

Epidermal growth factor inhibitors in first-line for metastatic colorectal cancer with ras wild-type: a perspective based on pharmacological costs

scientific article

FOLFIRINOX is a cost-effective combination chemotherapy in first-line for advanced pancreatic Cancer

scientific article published on 19 January 2019

Financial Toxicity and Non-small Cell Lung Cancer Treatment: The Optimization in the Choice of Immune Check Point Inhibitors

scientific article published on 01 July 2019

First-line therapies in metastatic colorectal cancer: integrating clinical benefit with the costs of drugs

scientific article published on 08 September 2018

Gastrointestinal stromal tumors and other malignancies: a case series.

scientific article published on December 2012

Gastrointestinal stromal tumors and second primary malignancies before and after the introduction of imatinib mesylate

scientific article published on October 2013

Immune-checkpoint inhibitors in head and neck squamous cell carcinoma: cost-efficacy in second-line treatment based on programmed death-ligand 1 (PD-L1) level

scientific article published on 17 August 2019

Immunotherapy and Targeted Therapies in Metastatic Renal Cell Carcinoma: Is There a Preferred Sequence? ⬇️

scientific article published on June 27, 2012

Immunotherapy in first-line for advanced non-small cell lung cancer: a cost-effective choice?

scientific article published on 01 March 2019

Intraperitoneal hyperthermic chemotherapy: which drugs?

scientific article published on 01 March 2014

Intravenous midline catheter usage: which clinical impact in homecare patients?

scientific article published on 21 April 2013

Is there a real need of adjuvant chemotherapy for locally advanced nasopharyngeal carcinoma?

scientific article published on 01 September 2014

La combinazione di gemcitabina e oxaliplatino (GEMOX) nel trattamento del carcinoma pancreatico in fase avanzata di malattia: le notizie sulla mia morte sono state esagerate?

scientific article published in December 2017

Late recurrence (more than 10 years) in early (tumors equal to or smaller than 2 cm) breast cancer patients

scientific article published on 30 October 2015

Light and shadow on innovative clinical trial designs: reflections from the EORTC-PAMM course on 'preclinical and early-phase clinical pharmacology'

scientific article published on 30 October 2019

Liver metastases from primary rectal cancer: a multidisciplinary reverse approach.

scientific article

Long-term survival in advanced pancreatic cancer

scientific article published on 01 June 2018

Management of advanced pancreatic cancer in daily clinical practice.

scientific article

Netupitant plus palonosetron is a cost-effective treatment for the prophylaxis of chemotherapy-induced nausea and vomiting in highly and moderately emetogenic cancer treatment

scientific article published on 04 August 2019

Nivolumab Is a Cost-Effective Second-Line Treatment for Metastatic Renal-Cell Carcinoma.

scientific article published on 22 February 2018

Nivolumab in Second-Line Treatment for Advanced Non-Small-Cell Lung Cancer With Squamous-Cell Histology: A Perspective Based on Pharmacologic Costs

scientific article published on 23 April 2017

Off-label prescription of anti-cancer drugs in Italy: what responsibilities?

scientific article published in July 2013

Oncological quality indicators and Colorectal Cancer Program: data from 2009-2010 of University Hospital in Ferrara, Italy

scientific article published on February 1, 2012

P-050The pharmacological costs of first-line therapies in unselected advanced colorectal cancer patients: a review of published phase III trials.

scientific article

Palbociclib or Ribociclib in First-Line Treatment in Patients With Hormone Receptor-Positive/Human Epidermal Receptor 2-Negative Advanced or Metastatic Breast Cancer? A Perspective Based on Pharmacologic Costs

scientific article published on 16 February 2019

Pharmacologic Costs of Tyrosine Kinase Inhibitors in First-Line Therapy for Advanced Non-Small-Cell Lung Cancer With Activating Epidermal Growth Factor Receptor Mutations: A Review of Pivotal Phase III Randomized Controlled Trials

scientific article published on 17 December 2015

Primary Malignant Fibrous Histiocytoma of Vater’s Papilla: First Reported Case ⬇️

scientific article published on 01 September 2013

Primary TKI resistance in advanced non-small cell lung cancer with EGFR mutation: an open question.

scientific article published on 24 July 2015

Radically resected pancreatic cancer and adjuvant treatment. A review of the literature

scientific article

Re: Michal Sarfaty, Moshe Leshno, Noa Gordon, et al. Cost Effectiveness of Nivolumab in Advanced Renal Cell Carcinoma. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2017.07.041: Second-line Treatment in Metastatic Renal Cell Carcinoma. Can

scientific article published on 31 October 2017

Regorafenib or Trifluridine/Tipiracil in Refractory Metastatic Colorectal Cancer? A Perspective on the Basis of Pharmacological Costs

scientific article published on 23 February 2018

Second-Line Treatment in Elderly Patients With Advanced Non-Small-Cell Lung Cancer

scientific article published on 10 November 2015

Skin rash during cetuximab treatment in advanced colorectal cancer: is age a clinical predictor?

scientific article published in June 2013

Spinal tuberculosis simulating metastatic malignancy: an unusual condition

scientific article published in January 2014

Targeted agents and oxaliplatin-containing regimens for the treatment of colon cancer

scientific article published on January 2014

The Economic Impact of Biosimilars in Oncology and Hematology: The Case of Trastuzumab and Rituximab

scientific article published on 01 July 2019

The European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS) applied to pivotal phase III randomized-controlled trials of tyrosine kinase inhibitors in first-line for advanced non-small cell lung cancer with activating e

scientific article published on 10 November 2016

The Multidisciplinary Management of Cancer in Daily Clinical Practice: Towards a Community Hospital Comprehensive Cancer Center.

scientific article published in March 2016

The Occurrence of Gastrointestinal Stromal Tumors and Second Malignancies

scientific article published on 04 September 2015

The Onset of Grade ≥3 Neutropenia Is Associated With Longer Overall Survival in Metastatic Colorectal Cancer Patients Treated With Trifluridine/Tipiracil

scientific article published on 01 July 2019

The Pharmacological Costs for the Management of Skin Toxicity in Patients With Cancer Treated With Epidermal Growth Factor Receptor-Inhibitors.

scientific article published on 5 May 2016

The Pharmacological Costs of Complete Liver Resections in Unselected Advanced Colorectal Cancer Patients: Focus on Targeted Agents. A Review of Randomized Clinical Trials

scientific article

The Pharmacological Costs of First-Line Therapies in Unselected Patients With Advanced Colorectal Cancer: A Review of Published Phase III Trials

scientific article published on 19 July 2016

The Pharmacological Costs of Second-Line Treatments for Recurrent Ovarian Cancer

scientific article published on 3 October 2017

The coexistence of second and third malignancies in adult-onset cancer patients

scientific article published on 01 September 2014

The cost-effectiveness of trastuzumab emtansine (T-DM1) in HER2-positive metastatic breast cancer is supported by clinical evidence

scientific article published on 13 September 2020

The development of hypertension in metastatic colorectal cancer patients treated with aflibercept: the role of systolic and diastolic blood pressure before starting treatment.

scientific article

The effect of palliative care on the assistance of terminally ill cancer patients

scientific article published on 08 June 2013

The exposure to perfluoroalkyl substances (PFAS) and the development of cancer

scientific article published on 01 July 2019

The introduction of a third CDK4/6 inhibitor does not change the cost-effectiveness profile in first and subsequent-lines after progression or relapse during previous endocrine therapy in patients with hormone receptor positive (HR+)/human epidermal

scientific article published on 23 June 2020

The management of skin toxicity during cetuximab treatment in advanced colorectal cancer: how much does it cost? A retrospecive economic assessment from a single-center experience.

scientific article published in July 2012

The management of skin toxicity during erlotinib in advanced non-small cell lung cancer: how much does it cost?

scientific article published in February 2013

The outcome of targeted therapies in patients with poor prognosis metastatic renal cell carcinoma

scientific article published on 01 July 2014

The pharmacological costs of complete liver resections in unselected advanced colorectal cancer patients treated with targeted agents.

scientific article

The pharmacological costs of complete liver resections in unselected advanced colorectal cancer patients: a review of published Phase II and III trials

scientific article

The role of fentanyl in the treatment of breakthrough cancer pain: Different biotechnologies, different results and different drug costs

scientific article published on 26 December 2020

The role of palliative surgery in the management of advanced pancreatic cancer in patients with biliary and duodenal obstruction

scientific article published on 29 January 2016

Thromboembolic disease in advanced colorectal cancer treated with chemotherapy and bevacizumab: a case of real "pan-thrombosis".

scientific article published in January 2015

To perform genotyping of dihydropyrimidine dehydrogenase (DPD) before starting treatment with 5-fluorouracil or related medicines: really feasible?

scientific article published on 14 September 2020

Trends in survival for patients with metastatic breast cancer: is survival improving?

scientific article published on 30 April 2015

Which grade is of clinical benefit in the randomised controlled trials? The example of 54th American Society of Clinical Oncology annual meeting, 2018

scientific article published on 11 October 2018

[Platinum antitumor complexes].

scientific article published in December 2015

Paulina is supported by:

About Paulina

Help